More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

Malta cimetra production facility update

Nov 2, 2021 at 9:35 PM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Nov 2, 2021 at 9:35 PM EDT

On 6ix: 6ix.com/news/malta-cimetra-production-facility-update

Argent Biopharma Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Argent Biopharma Ltd on 6ix

Story so far

  • Patent application lodged for novel drug delivery systemJul 15, 2021
  • MGC Pharma COVID-19 Business and Operations UpdateApr 6, 2020

Earlier from Argent Biopharma

  • Cimetra dose finding study approvalNov 1, 2021
  • Response to ASX Query LetterOct 15, 2021
  • Amc inc. places US$3M cimetra purchase orderOct 6, 2021
  • First order received under US supply agreementSep 29, 2021
  • Artemic eu sale approval and clinical trial updateSep 15, 2021

Later from Argent Biopharma

  • US Supply and Distribution Agreement UpdateNov 22, 2021
  • Production Completed of A$1M ArtemiC Order from SPCNov 24, 2021
  • UK Capital Raising CompletedDec 1, 2021
  • ArtemiC Long COVID Syndrome Clinical Study CommencedDec 20, 2021
  • ArtemiC receives Indian importation and sales approvalJan 6, 2022
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer